{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:42:19Z","timestamp":1790505739055,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1124\/jpet.111.180794","type":"journal-article","created":{"date-parts":[[2011,3,29]],"date-time":"2011-03-29T22:04:23Z","timestamp":1301436263000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cinnamyl-3,4-Dihydroxy-\u03b1-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase"],"prefix":"10.1016","volume":"338","author":[{"given":"Carlo","family":"Pergola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Jazzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Buehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Luderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Dehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinnak","family":"Northoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sautebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.180794_bib1","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.2174\/138161209789058020","article-title":"Inhibitors of the 5-lipoxygenase pathway in atherosclerosis","volume":"15","author":"B\u00e4ck","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.111.180794_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1811199a0","article-title":"Antioxidant determinations by the use of a stable free radical","volume":"181","author":"Blois","year":"1958","journal-title":"Nature"},{"key":"10.1124\/jpet.111.180794_bib3","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.274.34.23679","article-title":"Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate","volume":"274","author":"Brash","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.180794_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1073\/pnas.92.1.107","article-title":"Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3","volume":"92","author":"Brungs","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.180794_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/bj3480329","article-title":"Positional- and stereo-selectivity of fatty acid oxygenation catalysed by mouse (12S)-lipoxygenase isoenzymes","volume":"348","author":"B\u00fcrger","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/jpet.111.180794_bib6","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1084\/jem.185.6.1065","article-title":"Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses","volume":"185","author":"Byrum","year":"1997","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.111.180794_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/372179a0","article-title":"Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene","volume":"372","author":"Chen","year":"1994","journal-title":"Nature"},{"key":"10.1124\/jpet.111.180794_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/jm00108a039","article-title":"Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase","volume":"34","author":"Cho","year":"1991","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.180794_bib9","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/ijc.23300","article-title":"Nox1 downstream of 12-lipoxygenase controls cell proliferation but not cell spreading of colon cancer cells","volume":"122","author":"de Carvalho","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1124\/jpet.111.180794_bib10","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1016\/j.bmc.2007.08.015","article-title":"Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries","volume":"15","author":"Deschamps","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.111.180794_bib11","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1016\/j.bmc.2006.01.057","article-title":"Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases","volume":"14","author":"Deschamps","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/jpet.111.180794_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1096\/fj.02-0815fje","article-title":"Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors","volume":"17","author":"Fischer","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/jpet.111.180794_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0300-483X(02)00198-1","article-title":"Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics","volume":"177","author":"Galati","year":"2002","journal-title":"Toxicology"},{"key":"10.1124\/jpet.111.180794_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1197203","article-title":"The structure of human 5-lipoxygenase","volume":"331","author":"Gilbert","year":"2011","journal-title":"Science"},{"key":"10.1124\/jpet.111.180794_bib15","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.00624.2010","article-title":"Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats","volume":"300","author":"Guo","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.111.180794_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2007.03.024","article-title":"Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors","volume":"566","author":"K\u00e4lvegren","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.180794_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Clinical practice. Chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.180794_bib18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.ATV.15.7.942","article-title":"A leukocyte type of 12-lipoxygenase is expressed in human vascular and mononuclear cells. Evidence for upregulation by angiotensin II","volume":"15","author":"Kim","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.111.180794_bib19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-2007-969427","article-title":"Studies on scutellariae radix; XIII. Effects of various flavonoids on arachidonate metabolism in leukocytes","volume":"51","author":"Kimura","year":"1985","journal-title":"Planta Med"},{"key":"10.1124\/jpet.111.180794_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.plipres.2006.02.003","article-title":"Inflammation and immune regulation by 12\/15-lipoxygenases","volume":"45","author":"K\u00fchn","year":"2006","journal-title":"Prog Lipid Res"},{"key":"10.1124\/jpet.111.180794_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1074\/jbc.273.3.1733","article-title":"Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts","volume":"273","author":"Kuwata","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.180794_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0165-6147(92)90100-K","article-title":"Designing therapeutically effective 5-lipoxygenase inhibitors","volume":"13","author":"McMillan","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.111.180794_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI115110","article-title":"Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells","volume":"87","author":"Nadel","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.111.180794_bib24","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1248\/cpb.39.1736","article-title":"Quantitative structure-activity relationship of catechol derivatives inhibiting 5-lipoxygenase","volume":"39","author":"Naito","year":"1991","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/jpet.111.180794_bib25","doi-asserted-by":"crossref","first-page":"19881","DOI":"10.1073\/pnas.0809120105","article-title":"ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma","volume":"105","author":"Pergola","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.111.180794_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/13543771003602012","article-title":"5-Lipoxygenase inhibitors: a review of recent developments and patents","volume":"20","author":"Pergola","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/jpet.111.180794_bib27","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.180794_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/med.20099","article-title":"Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs","volume":"28","author":"Pontiki","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1124\/jpet.111.180794_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"R\u00e5dmark","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/jpet.111.180794_bib30","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/0006-291X(82)91081-6","article-title":"Selective inhibition of platelet lipoxygenase by baicalein","volume":"105","author":"Sekiya","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.111.180794_bib31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/01.HYP.27.5.1149","article-title":"Platelet lipoxygenase in spontaneously hypertensive rats","volume":"27","author":"Stern","year":"1996","journal-title":"Hypertension"},{"key":"10.1124\/jpet.111.180794_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1006\/bbrc.2000.3390","article-title":"Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase","volume":"275","author":"Suzuki","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.111.180794_bib33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1388-1981(00)00017-2","article-title":"15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation","volume":"1484","author":"Tornhamre","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.111.180794_bib34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00063030-200115110-00004","article-title":"Pathophysiological role of leukotrienes in dermatological diseases: potential therapeutic implications","volume":"15","author":"Wedi","year":"2001","journal-title":"BioDrugs"},{"key":"10.1124\/jpet.111.180794_bib35","doi-asserted-by":"crossref","first-page":"C1212","DOI":"10.1152\/ajpcell.1996.271.4.C1212","article-title":"Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase","volume":"271","author":"Wen","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.111.180794_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1568010023344959","article-title":"5-Lipoxygenase: cellular biology and molecular pharmacology","volume":"1","author":"Werz","year":"2002","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1124\/jpet.111.180794_bib37","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood.V99.3.1044","article-title":"Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes","volume":"99","author":"Werz","year":"2002","journal-title":"Blood"},{"key":"10.1124\/jpet.111.180794_bib38","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/jm0201262","article-title":"Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase","volume":"45","author":"Whitman","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.180794_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2005.08.214","article-title":"Arachidonate 12-lipoxygenases with reference to their selective inhibitors","volume":"338","author":"Yamamoto","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.111.180794_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0090-6980(02)00034-5","article-title":"Arachidonate 12-lipoxygenases","volume":"68\u201369","author":"Yoshimoto","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.180794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:32:01Z","timestamp":1740000721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524464409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022356524464409"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.180794","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cinnamyl-3,4-Dihydroxy-\u03b1-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.180794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}